Bextra lawyers Philadelphia

Bextra, Celebrex and Vioxx

Bextra® lawyers in Philadelphia.

On April 7, 2005 the FDA announced that it has asked Pfizer, Inc. to withdraw Bextra from the market "because the overall risk versus benefit profile for the drug is unfavorable."

Check with your doctor about your treatment options.

Bextra® is a COX-2 selective agent. It is prescribed for inflammation and pain from arthritis or menstrual cramping. Other drugs in this class include Celebrex® and Vioxx®. Many doctors switched patients from Vioxx® to Bextra® when Merck voluntarily removed it from the market due studies showing an increased risk for heart attack and stroke.

bextra site map

For a free case evaluation from a Philadelphia attorney, click here: http://www.lawforum.net/areas/bextra/pennsylvania/philadelphia/
Munley, Munley & Cartwright, P.C. is a Pennsylvania law office which has breaking news and information about this lawsuit http://www.munley.com/drugs/bextra.html
Click here to read the FDA questions and answers about strengthened warnings on Bextra® boxes http://www.fda.gov/cder/drug/infopage/bextra/bextraQA.htm
To report any unexpected adverse or serious events associated with the use of Bextra® contact the FDA MedWatch program at: 1-800-FDA-1088 or on the Internet at http://www.fda.gov/medwatch/index.html

Autism Education Materials!